Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Pandey

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Oncotarget|November 5, 2017
Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cellsVijay Pandey, Min Zhang, Qing-Yun Chong, et al.
Nano Letters|February 21, 2025
Electron-Withdrawing Hexagonal Boron Nitride as a Biocompatible and Metal-Free Antibacterial PlatformJianxiang Gao, Hengyue Xu, Yingcan Zhao, et al.
Oncotarget|December 22, 2017
Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinomaJing-Jing Wang, Qing-Yun Chong, Xin-Bao Sun, et al.
Journal of Advanced Research|July 27, 2024
A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathwayMin Hee Yang, Basappa Basappa, Suresha N Deveshegowda, et al.
Oncotarget|April 23, 2016
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinomaXiangjun Kong, Wenyong Wu, Yan Yuan, et al.
Bioengineering (Basel, Switzerland)|February 25, 2023
De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer CellsAkshay Ravish, Rashmi Shivakumar, Zhang Xi, et al.
Pharmacological Research|November 27, 2022
Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectivesMohammad Arad Zandieh, Melika Heydari Farahani, Romina Rajabi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2018
Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylationVijay Pandey, Baocheng Wang, Chakrabhavi Dhananjaya Mohan, et al.
Mikrochimica Acta|July 17, 2024
Unraveling the influence of CRISPR/Cas13a reaction components on enhancing trans-cleavage activity for ultrasensitive on-chip RNA detectionQian He, Qun Chen, Lijin Lian, et al.
Chemistry & Biodiversity|January 23, 2024
Development of Novel Indazolyl-Acyl Hydrazones as Antioxidant and Anticancer Agents that Target VEGFR-2 in Human Breast Cancer CellsSindhu M Parameshwaraiah, Rashmi Shivakumar, Zhang Xi, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Oncotarget|November 5, 2017
Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cellsVijay Pandey, Min Zhang, Qing-Yun Chong, et al.
Nano Letters|February 21, 2025
Electron-Withdrawing Hexagonal Boron Nitride as a Biocompatible and Metal-Free Antibacterial PlatformJianxiang Gao, Hengyue Xu, Yingcan Zhao, et al.
Oncotarget|December 22, 2017
Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinomaJing-Jing Wang, Qing-Yun Chong, Xin-Bao Sun, et al.
Journal of Advanced Research|July 27, 2024
A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathwayMin Hee Yang, Basappa Basappa, Suresha N Deveshegowda, et al.
Oncotarget|April 23, 2016
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinomaXiangjun Kong, Wenyong Wu, Yan Yuan, et al.
Bioengineering (Basel, Switzerland)|February 25, 2023
De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer CellsAkshay Ravish, Rashmi Shivakumar, Zhang Xi, et al.
Pharmacological Research|November 27, 2022
Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectivesMohammad Arad Zandieh, Melika Heydari Farahani, Romina Rajabi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2018
Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylationVijay Pandey, Baocheng Wang, Chakrabhavi Dhananjaya Mohan, et al.
Mikrochimica Acta|July 17, 2024
Unraveling the influence of CRISPR/Cas13a reaction components on enhancing trans-cleavage activity for ultrasensitive on-chip RNA detectionQian He, Qun Chen, Lijin Lian, et al.
Chemistry & Biodiversity|January 23, 2024
Development of Novel Indazolyl-Acyl Hydrazones as Antioxidant and Anticancer Agents that Target VEGFR-2 in Human Breast Cancer CellsSindhu M Parameshwaraiah, Rashmi Shivakumar, Zhang Xi, et al.
Pageof 10